(Stroke. 1998;29:2381-2395.)
© 1998 American Heart Association, Inc.
Original Contributions |
Enhanced Neocortical Neural Sprouting, Synaptogenesis, and Behavioral Recovery With D-Amphetamine Therapy After Neocortical Infarction in Rats
From the School of Biological Sciences, Division of Neuroscience, University of Manchester, Manchester, England (R.P.S.), and Departments of Neurology (T.A.K.) and Anatomy and Neurosciences and Marine Biomedical Institute (C.E.H.), University of Texas Medical Branch, Galveston.
Correspondence to Dr C.E. Hulsebosch, Department of Anatomy and Neurosciences, 301 University Blvd 1069, University of Texas Medical Branch, Galveston, TX 77555-1069. E-mail CEHulseb{at}utmb.edu
Background and Purpose—D-Amphetamine administration increases behavioral recovery after various cortical lesions including cortical ablations, contusions, and focal ischemia in animals and after stroke in humans. The purpose of the present study was to test the enhanced behavioral recovery and increased expression of proteins involved in neurite growth and synaptogenesis in D-amphetamine–treated rats compared with vehicle-treated controls after a focal neocortical infarct.
Methods—Unilateral neocortical ischemia was induced in male spontaneously hypertensive Wistar rats (n=8 per time point per group) by permanently occluding the distal middle cerebral artery and ipsilateral common carotid artery in 2 groups of rats: D-amphetamine treated (2 mg/kg IP injections) and vehicle treated (saline IP injections). To determine the spatial and temporal distribution of neurite growth and/or synaptogenesis, growth-associated protein (GAP-43), a protein expressed on axonal growth cones, and synaptophysin, a calcium-binding protein found on synaptic vesicles, were examined by immunohistochemical techniques, and both density and distribution of reaction product were measured. Since the resulting infarction included a portion of the forelimb neocortex, behavioral assessments of forelimb function using the foot-fault test of Hernandez and Schallert were performed on the same rats used for immunohistochemical studies during the period of drug action and 24 hours later. A Morris water maze and other indices of behavioral assays were also measured similarly. Recovery times were 3, 7, 14, 30, and 60 days postoperatively.
Results—Both GAP-43 and synaptophysin proteins demonstrated statistically significant increases in density and distribution of immunoreaction product as determined by optical density measurements in the neocortex of the infarcted group treated with D-amphetamines compared with vehicle-treated infarcted controls. The GAP-43 was elevated to statistically significant levels in forelimb, hindlimb, and parietal neocortical regions ipsilateral to the infarction only at days 3, 7, and 14. By contrast, the synaptophysin demonstrated no statistically significant changes in expression at 3 or 7 days but demonstrated statistically significant increases at 14, 30, and 60 days in the forelimb, hindlimb, and parietal neocortical regions ipsilateral to the infarction as well as increased distribution in the contralateral parietal neocortex. Behavioral assessment of forelimb function indicated that improved recovery of forelimb placement on the side contralateral to the infarction was statistically significant in the D-amphetamine–treated group compared with the vehicle-treated group (P<0.025). Spatial memory, as measured with the Morris water maze, worsened in the vehicle-treated group compared with the D-amphetamine–treated group at 60 days (P<0.025).
Conclusions—These data support the occurrence of neurite growth followed by synaptogenesis in the neocortex in a pattern that corresponds both spatially and temporally with behavioral recovery that is accelerated by D-amphetamine treatment. While the specific mechanisms responsible for D-amphetamine–promoted expression of proteins involved in neurite growth and synaptogenesis and of enhanced behavioral recovery are not known, it is suggested that protein upregulation occurs as a result of functional activation of pathways able to remodel in response to active behavioral performance.
Editorial Comment
Departments of Psychology and Neurosciences University of New Mexico Albuquerque, NM
This article has been cited by other articles:
 |
|
 |
|
  J. W. Simpkins, E. Perez, Xiaofei Wang, ShaoHua Yang, Yi Wen, and M. Singh Review: The potential for estrogens in preventing Alzheimer's disease and vascular dementia Therapeutic Advances in Neurological Disorders, January 1, 2009; 2(1): 31 - 49. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Papadopoulos, S.-Y. Tsai, V. Guillen, J. Ortega, G. L. Kartje, and W. A. Wolf Motor Recovery and Axonal Plasticity With Short-Term Amphetamine After Stroke Stroke, January 1, 2009; 40(1): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Muller, K. M. Hanumanthiah, K. Diederich, S. Schwab, W.-R. Schabitz, and C. Sommer Brain-Derived Neurotrophic Factor But Not Forced Arm Use Improves Long-Term Outcome After Photothrombotic Stroke and Transiently Upregulates Binding Densities of Excitatory Glutamate Receptors in the Rat Brain Stroke, March 1, 2008; 39(3): 1012 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Obrenovitch Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia Physiol Rev, January 1, 2008; 88(1): 211 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Butler and S. L Wolf Putting the Brain on the Map: Use of Transcranial Magnetic Stimulation to Assess and Induce Cortical Plasticity of Upper-Extremity Movement Physical Therapy, June 1, 2007; 87(6): 719 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Jin, D. A. Prince, and J. R. Huguenard Enhanced excitatory synaptic connectivity in layer v pyramidal neurons of chronically injured epileptogenic neocortex in rats. J. Neurosci., May 3, 2006; 26(18): 4891 - 4900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shimamura, N. Sato, S. Waguri, Y. Uchiyama, T. Hayashi, H. Iida, T. Nakamura, T. Ogihara, Y. Kaneda, and R. Morishita Gene Transfer of Hepatocyte Growth Factor Gene Improves Learning and Memory in the Chronic Stage of Cerebral Infarction Hypertension, April 1, 2006; 47(4): 742 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Cramer, R. Shah, J. Juranek, K. R. Crafton, and V. Le Activity in the Peri-Infarct Rim in Relation to Recovery From Stroke Stroke, January 1, 2006; 37(1): 111 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gladstone, C. J. Danells, A. Armesto, W. E. McIlroy, W. R. Staines, S. J. Graham, N. Herrmann, J. P. Szalai, S. E. Black, and for the Subacute Therapy with Amphetamine and Reha Physiotherapy Coupled With Dextroamphetamine for Rehabilitation After Hemiparetic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial Stroke, January 1, 2006; 37(1): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N S Ward Mechanisms underlying recovery of motor function after stroke Postgrad. Med. J., August 1, 2005; 81(958): 510 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-K. Lee, J.-E. Kim, M. Sivula, and S. M. Strittmatter Nogo Receptor Antagonism Promotes Stroke Recovery by Enhancing Axonal Plasticity J. Neurosci., July 7, 2004; 24(27): 6209 - 6217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-R. Schabitz, C. Berger, R. Kollmar, M. Seitz, E. Tanay, M. Kiessling, S. Schwab, and C. Sommer Effect of Brain-Derived Neurotrophic Factor Treatment and Forced Arm Use on Functional Motor Recovery After Small Cortical Ischemia Stroke, April 1, 2004; 35(4): 992 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Long and J. Young Dexamphetamine treatment in stroke QJM, September 1, 2003; 96(9): 673 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Carmichael Plasticity of Cortical Projections after Stroke Neuroscientist, February 1, 2003; 9(1): 64 - 75. [Abstract] [PDF]
|
|
|
|
|
|
L. Martinsson and N. G. Wahlgren Safety of Dexamphetamine in Acute Ischemic Stroke: A Randomized, Double-Blind, Controlled Dose-Escalation Trial Stroke, February 1, 2003; 34(2): 475 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-D. Troadec, M. Marien, S. Mourlevat, T. Debeir, M. Ruberg, F. Colpaert, and P. P. Michel Activation of the Mitogen-Activated Protein Kinase (ERK1/2) Signaling Pathway by Cyclic AMP Potentiates the Neuroprotective Effect of the Neurotransmitter Noradrenaline on Dopaminergic Neurons Mol. Pharmacol., November 1, 2002; 62(5): 1043 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gladstone, S. E. Black, and A. M. Hakim Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions Stroke, August 1, 2002; 33(8): 2123 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hallett Recent Advances in Stroke Rehabilitation Neurorehabil Neural Repair, June 1, 2002; 16(2): 211 - 217. [PDF]
|
|
|
|
 |
|
 G.-C. Yeh, J.-C. Chen, H.-C. Tsai, H.-H. Wu, C.-Y. Lin, P.-C. Hsu, and Y.-C. Peng Amphetamine Inhibits the N-Methyl-D-Aspartate Receptor-Mediated Responses by Directly Interacting with The Receptor/Channel Complex J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1008 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Roof, G. P. Schielke, X. Ren, and E. D. Hall A Comparison of Long-Term Functional Outcome After 2 Middle Cerebral Artery Occlusion Models in Rats Stroke, November 1, 2001; 32(11): 2648 - 2657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Walker-Batson, S. Curtis, R. Natarajan, J. Ford, N. Dronkers, E. Salmeron, J. Lai, D. H. Unwin, and D. M. Feeney A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of Aphasia Editorial Comment Stroke, September 1, 2001; 32(9): 2093 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Veizovic, J. S. Beech, R. P. Stroemer, W. P. Watson, and H. Hodges Resolution of Stroke Deficits Following Contralateral Grafts of Conditionally Immortal Neuroepithelial Stem Cells Stroke, April 1, 2001; 32(4): 1012 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, T. Hayashi, C.-F. Chang, Y.-H. Chiang, L.-I Tsao, T.-P. Su, C. Borlongan, and S.-Z. Lin Methamphetamine Potentiates Ischemia/Reperfusion Insults After Transient Middle Cerebral Artery Ligation Stroke, March 1, 2001; 32(3): 775 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Cramer, G. Nelles, J. D. Schaechter, J. D. Kaplan, S. P. Finklestein, and B. R. Rosen A Functional MRI Study of Three Motor Tasks in the Evaluation of Stroke Recovery Neurorehabil Neural Repair, January 1, 2001; 15(1): 1 - 8. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Fisher and W. Schaebitz An Overview of Acute Stroke Therapy: Past, Present, and Future Arch Intern Med, November 27, 2000; 160(21): 3196 - 3206. [Full Text] [PDF]
|
|
|
|
|
|
S. T. Bland, T. Schallert, R. Strong, J. Aronowski, J. C. Grotta, and D. M. Feeney Early Exclusive Use of the Affected Forelimb After Moderate Transient Focal Ischemia in Rats : Functional and Anatomic Outcome Editorial Comment: Functional and Anatomic Outcome Stroke, May 1, 2000; 31(5): 1144 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Cramer, C. I. Moore, S. P. Finklestein, and B. R. Rosen A Pilot Study of Somatotopic Mapping After Cortical Infarct Stroke, March 1, 2000; 31(3): 668 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Johansson Brain Plasticity and Stroke Rehabilitation : The Willis Lecture Stroke, January 1, 2000; 31(1): 223 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development Stroke, December 1, 1999; 30(12): 2752 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein and C. E. Hulsebosch Amphetamine-Facilitated Poststroke Recovery • Response Stroke, March 1, 1999; 30(3): 696 - 698. [Full Text] [PDF]
|
|